Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze GILD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate GILD investment potential.

What is GILD stock price today?

Get real-time GILD stock price, historical data, and price charts on Financhill. Track GILD performance with our advanced analysis tools.

Is GILD a good investment?

Evaluate GILD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy GILD stock?

To buy GILD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of GILD?

View detailed market capitalization data and company valuation metrics for GILD on our comprehensive analysis page.

What is the P/E ratio of GILD?

Use our fundamental analysis tools to view GILD P/E ratio and compare valuation metrics with industry peers.

What are GILD earnings?

View GILD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Gilead Sciences, Inc. 10K Form

Buy

GILD
Gilead Sciences, Inc.

Last Price:

$122.59

Seasonality Move:

8.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2025-11-15	10K	GILD/Gilead Sciences, Inc. Annual
2025-10-15	10K	GILD/Gilead Sciences, Inc. Annual
2025-09-15	10K	GILD/Gilead Sciences, Inc. Annual
2024-05-08	10Q	GILD/Gilead Sciences, Inc. Quarterly
2024-02-23	10K	GILD/Gilead Sciences, Inc. Annual
2023-11-07	10Q	GILD/Gilead Sciences, Inc. Quarterly

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales:	$28.7B
Cash Flow:	$4B
Price / Cash Flow:	17.15
Annual Sales:	$17.34
Price / Book:	7.2

Profitability

EPS (TTM):	6.45630
Net Income (TTM):	$8.1B
Gross Margin:	$22.5B
Return on Equity:	41.48%
Return on Assets:	14.27%

Gilead Sciences, Inc. Earnings Forecast

Key Gilead Sciences, Inc. Financial Ratios

The Gross Profit Margin over the past 34 years for GILD is 78.24%.
The Selling, General & Administrative Expenses for GILD have been equal to 21.20% of Gross Profit Margin.
The Research & Development expenses have been 20.25% of Revenue.
The Interest Expense is 203.54% of Operating Income.
The Net Earning history of GILD is 1.67% of Total Revenues.
Per Share Earnings over the last 34 years have been positive in 20 years.

Gilead Sciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	GILD
CUSIP:	375558
Website:	gilead.com

Debt

Debt-to-Equity Ratio:	1.16
Current Ratio:	1.45
Quick Ratio:	1.16

Price-to-Earnings

Trailing P/E Ratio:	326.8
Forward P/E Ratio:	14.34

GILD Technical Analysis vs Fundamental Analysis

Buy

Gilead Sciences, Inc. (GILD) is a Buy

Is Gilead Sciences, Inc. a Buy or a Sell?

Gilead Sciences, Inc. stock is rated a Buy

The current Gilead Sciences, Inc. [GILD] share price is $122.62. The Score for GILD is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.